Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors. (2021)
Attributed to:
Accelerated Discovery and Development of New Medicines: Prosperity Partnership for a Healthier Nation
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.1c00344
PubMed Identifier: 34260229
Publication URI: http://europepmc.org/abstract/MED/34260229
Type: Journal Article/Review
Volume: 64
Parent Publication: Journal of medicinal chemistry
Issue: 15
ISSN: 0022-2623